(NASDAQ: QDEL) Quidelortho's forecast annual revenue growth rate of -1.81% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 10.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 20.38%.
Quidelortho's revenue in 2025 is $2,817,700,000.On average, 4 Wall Street analysts forecast QDEL's revenue for 2025 to be $186,073,778,387, with the lowest QDEL revenue forecast at $183,879,864,278, and the highest QDEL revenue forecast at $189,053,250,950.
In 2026, QDEL is forecast to generate $193,971,465,637 in revenue, with the lowest revenue forecast at $191,076,332,997 and the highest revenue forecast at $198,709,970,377.